Targeting duodenum to reverse MASLD

Yu JW et al. (World J Gastroenterol. 2025;31:105188. DOI: 10.3748/wjg.v31.i16.105188) used male Sprague-Dawley rats fed a high-fat diet for 8 weeks to recapitulate metabolic dysfunction-associated steatotic liver disease (MASLD) experimentally. MASLD rats were randomized to receive either the duoden...

Full description

Saved in:
Bibliographic Details
Main Authors: Amedeo Lonardo, Ming-Hua Zheng
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-06-01
Series:Exploration of Digestive Diseases
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100577/100577.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849422936464687104
author Amedeo Lonardo
Ming-Hua Zheng
author_facet Amedeo Lonardo
Ming-Hua Zheng
author_sort Amedeo Lonardo
collection DOAJ
description Yu JW et al. (World J Gastroenterol. 2025;31:105188. DOI: 10.3748/wjg.v31.i16.105188) used male Sprague-Dawley rats fed a high-fat diet for 8 weeks to recapitulate metabolic dysfunction-associated steatotic liver disease (MASLD) experimentally. MASLD rats were randomized to receive either the duodenal mucosal ablation (DMA) using irreversible electroporation (IRE) during laparotomy or sham DMA. Data have shown that DMA was associated with duodenal thickening compared to the control group, crypts were narrower and shallower crypts and villi slimmer than sham DMA group. Moreover, the DMA group exhibited improved liver histology compared to the sham group though accompanied by inconsistent variations in blood lipid values and statistically non-significant variations in surrogate indices of MASLD. Thirdly, DMA rats had lower serum concentrations of gut hormones with crucial metabolic functions, lower lipopolysaccharide serum level, increased duodenal expression and immunofluorescence staining intensity of gut hormones expression, and higher expression of zonula occludens-1 and claudin than sham-rats. The study by Yu, et al. has innovative findings and is properly designed to illustrate the pathomechanisms underlying improved MASLD histology after DMA with IRE. However, this paper also has some methodological limitations that prompt additional studies in animal models and, ideally, in humans to be conducted as soon as safety and feasibility are demonstrated.
format Article
id doaj-art-be02b80d007c4e6e9c3d5b5186ff9f06
institution Kabale University
issn 2833-6321
language English
publishDate 2025-06-01
publisher Open Exploration Publishing Inc.
record_format Article
series Exploration of Digestive Diseases
spelling doaj-art-be02b80d007c4e6e9c3d5b5186ff9f062025-08-20T03:30:52ZengOpen Exploration Publishing Inc.Exploration of Digestive Diseases2833-63212025-06-01410057710.37349/edd.2025.100577Targeting duodenum to reverse MASLDAmedeo Lonardo0https://orcid.org/0000-0001-9886-0698Ming-Hua Zheng1https://orcid.org/0000-0003-4984-2631Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena (–2023), Modena, 41100, ItalyMAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang, China; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou 325000, Zhejiang, ChinaYu JW et al. (World J Gastroenterol. 2025;31:105188. DOI: 10.3748/wjg.v31.i16.105188) used male Sprague-Dawley rats fed a high-fat diet for 8 weeks to recapitulate metabolic dysfunction-associated steatotic liver disease (MASLD) experimentally. MASLD rats were randomized to receive either the duodenal mucosal ablation (DMA) using irreversible electroporation (IRE) during laparotomy or sham DMA. Data have shown that DMA was associated with duodenal thickening compared to the control group, crypts were narrower and shallower crypts and villi slimmer than sham DMA group. Moreover, the DMA group exhibited improved liver histology compared to the sham group though accompanied by inconsistent variations in blood lipid values and statistically non-significant variations in surrogate indices of MASLD. Thirdly, DMA rats had lower serum concentrations of gut hormones with crucial metabolic functions, lower lipopolysaccharide serum level, increased duodenal expression and immunofluorescence staining intensity of gut hormones expression, and higher expression of zonula occludens-1 and claudin than sham-rats. The study by Yu, et al. has innovative findings and is properly designed to illustrate the pathomechanisms underlying improved MASLD histology after DMA with IRE. However, this paper also has some methodological limitations that prompt additional studies in animal models and, ideally, in humans to be conducted as soon as safety and feasibility are demonstrated.https://www.explorationpub.com/uploads/Article/A100577/100577.pdfduodenal mucosa ablationirreversible electroporationmetabolic dysfunction-associated steatotic liver diseasetype 2 diabetes
spellingShingle Amedeo Lonardo
Ming-Hua Zheng
Targeting duodenum to reverse MASLD
Exploration of Digestive Diseases
duodenal mucosa ablation
irreversible electroporation
metabolic dysfunction-associated steatotic liver disease
type 2 diabetes
title Targeting duodenum to reverse MASLD
title_full Targeting duodenum to reverse MASLD
title_fullStr Targeting duodenum to reverse MASLD
title_full_unstemmed Targeting duodenum to reverse MASLD
title_short Targeting duodenum to reverse MASLD
title_sort targeting duodenum to reverse masld
topic duodenal mucosa ablation
irreversible electroporation
metabolic dysfunction-associated steatotic liver disease
type 2 diabetes
url https://www.explorationpub.com/uploads/Article/A100577/100577.pdf
work_keys_str_mv AT amedeolonardo targetingduodenumtoreversemasld
AT minghuazheng targetingduodenumtoreversemasld